Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH.
JHEP Rep. 2024 Jan 19;6(4):101011. doi: 10.1016/j.jhepr.2024.101011. eCollection 2024 Apr.
JHEP Rep. 2024.
PMID: 38463540
Free PMC article.
NIS2+TM as a screening tool to optimize patient selection in metabolic dysfunction-associated steatohepatitis clinical trials.
Ratziu V, Harrison SA, Hajji Y, Magnanensi J, Petit S, Majd Z, Delecroix E, Rosenquist C, Hum D, Staels B, Anstee QM, Sanyal AJ.
Ratziu V, et al. Among authors: magnanensi j.
J Hepatol. 2024 Feb;80(2):209-219. doi: 10.1016/j.jhep.2023.10.038. Epub 2023 Dec 5.
J Hepatol. 2024.
PMID: 38061448
Free article.
Item in Clipboard
NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older.
Sanyal AJ, Magnanensi J, Majd Z, Rosenquist C, Vera DM, Almas JP, Connelly MA.
Sanyal AJ, et al. Among authors: magnanensi j.
Hepatol Commun. 2023 Aug 9;7(9):e0223. doi: 10.1097/HC9.0000000000000223. eCollection 2023 Sep 1.
Hepatol Commun. 2023.
PMID: 37556372
Free PMC article.
Item in Clipboard
NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study.
Harrison SA, Ratziu V, Magnanensi J, Hajji Y, Deledicque S, Majd Z, Rosenquist C, Hum DW, Staels B, Anstee QM, Sanyal AJ.
Harrison SA, et al. Among authors: magnanensi j.
J Hepatol. 2023 Sep;79(3):758-767. doi: 10.1016/j.jhep.2023.04.031. Epub 2023 May 22.
J Hepatol. 2023.
PMID: 37224923
Free article.
Item in Clipboard
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study.
Harrison SA, Ratziu V, Boursier J, Francque S, Bedossa P, Majd Z, Cordonnier G, Sudrik FB, Darteil R, Liebe R, Magnanensi J, Hajji Y, Brozek J, Roudot A, Staels B, Hum DW, Megnien SJ, Hosmane S, Dam N, Chaumat P, Hanf R, Anstee QM, Sanyal AJ.
Harrison SA, et al. Among authors: magnanensi j.
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):970-985. doi: 10.1016/S2468-1253(20)30252-1. Epub 2020 Aug 5.
Lancet Gastroenterol Hepatol. 2020.
PMID: 32763196
Clinical Trial.
Item in Clipboard
Cite
Cite